Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer

NCT00005886 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: arzoxifene hydrochloride
DRUG: tamoxifen citrate

Sponsor

University of Kansas Medical Center

Collaborators

[object Object]